Chemo: IV vs. Pills, A Matter of Cost in Your State

Written by Julia Thayer, OCRA’s Associate Director, Advocacy Federal Rulemaking Update: Proposed Update to Uniform Guidance Advocacy isn’t limited to legislation and federal funding. This month, OCRA submitted a public comment on a proposed federal rule that could significantly impact how biomedical research is funded and conducted. On May 29, 2026, the Office of Management … Continued

Nearly 500 people have already registered for OCRA’s International Gynecologic Cancer Conference®—the largest conference dedicated to the gynecologic cancer community—taking place on September 16–17. The conference is free, online, and open to all, and will include programming for ovarian, endometrial, cervical, and rare gynecologic cancers. For the first time, each of these diseases will have a dedicated Ask the Experts session. Learn … Continued

Written by Julia Thayer, OCRA’s Associate Director, Advocacy Federal Funding Update: Two Priorities Gain Ground There’s encouraging news to share from this year’s federal funding process: two of OCRA’s top priorities are in line for more funding than they received last year. The House Appropriations Committee has recommended increases for both Johanna’s Law and the … Continued